Tuesday, Jan 27 / 2026
Virtual Meeting
  • Tuesday, January 27, 2026
  • 02:00 PM - 03:00 PM PST
  • Virtual Only
  • → Join Online
  • Access will be granted upon approval
Download for Outlook/Apple Calendar Add to Google Calendar

DD Call with QuantaPro

QuantaPro
QuantaPro enables oncologists to determine—early and in real time—whether chemotherapy will work, using a single drop of blood. Beginning with the ERCC1 chemo-resistance test, the company addresses a long-standing clinical blind spot in oncology while building a scalable, high-margin proteomic testing platform that will expand to other chronic diseases.

Presenting companies:

QuantaPro
QuantaPro

QuantaPro enables oncologists to determine—early and in real time—whether chemotherapy will work, using a single drop of blood. Beginning with the ERCC1 chemo-resistance test, the company addresses a long-standing clinical blind spot in oncology while building a scalable, high-margin proteomic testing platform that will expand to other chronic diseases.